Lorraine L. Janeczko, MPH

Study results show hyponatremia is closely associated with all-cause mortality in patients with chronic kidney disease (CKD), but few previous studies have examined this relationship.

According to the authors of a recent study, almost 50% of patients with end-stage renal disease (ESRD) say they have chronic pain, and over 75% of them rate it as being moderate to severe.

A recent anonymous survey among nephrologists suggests that patients' social support, ability to understand the transplant process, and age are the most important factors influencing nephrologists' decisions to exclude them from kidney transplant referral.

A recent study suggests that dialysis patients' use of opioid analgesics (OAs) is widespread and exceeding historical limits, and that the patients who use opioids are staying on them longer.

Though patients with chronic kidney disease (CKD) have variable risks of death, the population risk prediction tools that are currently available perform poorly.

A recent study found that drug regimens containing renin-angiotensin system (RAS) inhibitors are associated with a lower risk of cardiovascular and all-cause deaths among patients starting hemodialysis, compared to regimens containing only beta blockers (BBs).

Patients who have chronic kidney disease (CKD) and end-stage renal disease (ESRD) require 20% less warfarin and more monitoring for bleeding than patients who have normal kidney function.

After developing a predictive model that compares a patient's individualized risk of mortality while undergoing dialysis to the risk of kidney transplant, a research team has created a free mobile app called iChoose Kidney that enables patients and providers to make informed decisions on treatment choices.

Results of a recent community-based study suggest that African-American patients are at higher risk for acute kidney injury (AKI) than Caucasians - a difference that appears to be related to disparities in income and socioeconomic status.

A recent study presented at Kidney Week 2013 suggests that a plain X-ray is a reliable and inexpensive tool for assessing the risks of cardiovascular events and death in patients who have chronic kidney disease (CKD) and are not on dialysis.